These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11460419)

  • 1. [Optimized therapy. Greater rate of effectiveness with consensus interferon].
    MMW Fortschr Med; 2001 Jun; 143(23):40-1. PubMed ID: 11460419
    [No Abstract]   [Full Text] [Related]  

  • 2. [Consensus and peg-interferon in chronic hepatitis C. Therapy for refractory cases?].
    Kaiser S
    MMW Fortschr Med; 2001 Apr; 143(16):36-7. PubMed ID: 11367991
    [No Abstract]   [Full Text] [Related]  

  • 3. [Consensus interferon. Problematic patients are not a problem].
    MMW Fortschr Med; 2001 Jun; 143(23):41. PubMed ID: 11460420
    [No Abstract]   [Full Text] [Related]  

  • 4. Consensus interferon induced interstitial pneumonitis in a patient with HCV.
    Hillier AE; Mand J; Raza A; Markov M; Nadir A
    Am J Gastroenterol; 2006 Jan; 101(1):200-2. PubMed ID: 16405558
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon plus ribavirin for chronic hepatitis C.
    Med Lett Drugs Ther; 1999 Jun; 41(1054):53-4. PubMed ID: 10368698
    [No Abstract]   [Full Text] [Related]  

  • 6. [Consensus interferon: a new weapon in the treatment of chronic hepatitis C].
    Vespasiani Gentilucci U; Picardi A
    Clin Ter; 2000; 151(3):211-2. PubMed ID: 10958058
    [No Abstract]   [Full Text] [Related]  

  • 7. Pegylated interferon: new preparation. Chronic hepatitis C: advantageous for some patients, but more data needed.
    Prescrire Int; 2003 Dec; 12(68):206-10. PubMed ID: 14986684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction therapy in chronic hepatitis C: déjà-vu with pegylated interferons?
    Zeuzem S
    J Hepatol; 2004 Sep; 41(3):488-90. PubMed ID: 15336454
    [No Abstract]   [Full Text] [Related]  

  • 9. High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study.
    da Silva LC; Bassit L; Ono-Nita SK; Pinho JR; Nishiya A; Madruga CL; Carrilho FJ
    J Gastroenterol; 2002; 37(9):732-6. PubMed ID: 12375147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expectations for results of clinical trial "IDEAL"].
    Simon K
    Przegl Epidemiol; 2006; 60(1):127-32. PubMed ID: 16758751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Maintenance" treatment for patients with cirrhosis related to hepatitis C.
    Gross JB
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):427-9. PubMed ID: 17445750
    [No Abstract]   [Full Text] [Related]  

  • 12. [When standard therapy fails. New therapy options in chronic hepatitis C].
    MMW Fortschr Med; 2001 Jan; 143(3):53-4. PubMed ID: 11215347
    [No Abstract]   [Full Text] [Related]  

  • 13. Pegylated interferon (PEG-Intron) for chronic hepatitis C.
    Med Lett Drugs Ther; 2001 Jun; 43(1107):54-5. PubMed ID: 11426190
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of hepatitis C.
    Heathcote J; Main J
    J Viral Hepat; 2005 May; 12(3):223-35. PubMed ID: 15850462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic hepatitis C. Better treatment outcome with pegylated interferon].
    MMW Fortschr Med; 2001 Mar; 143(13):51. PubMed ID: 11332022
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic and clinical effects of evaluating rapid viral response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C.
    Wong JB; Davis GL; McHutchison JG; Manns MP; Albrecht JK;
    Am J Gastroenterol; 2003 Nov; 98(11):2354-62. PubMed ID: 14638334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pegylated interferon sets a new standard. Better prognosis for hepatitis C infected patients].
    MMW Fortschr Med; 2002 May; 144(21):56. PubMed ID: 12138886
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiviral therapy for chronic hepatitis C.
    Sievert W
    Aust Fam Physician; 2003 Oct; 32(10):826-32. PubMed ID: 14596080
    [No Abstract]   [Full Text] [Related]  

  • 19. Infergen (interferon alfacon-1).
    Gastroenterol Nurs; 1998; 21(1):30-1. PubMed ID: 9555366
    [No Abstract]   [Full Text] [Related]  

  • 20. [New therapeutic possibilities in chronic hepatitis C].
    Criblez DH
    Praxis (Bern 1994); 2000 Mar; 89(11):450-3. PubMed ID: 10758732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.